This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:
Dimethylsulfoxide (DMSO) has been shown to be an active agent against ocular and intraocular inflammations. Its results have been so variable and unpredictable as to indicate that much is still to be learned about its proper usage. For that reason I have not attempted a more detailed analysis of my series of cases treated. However, the number of inquiries addressed to me prompt this letter.In over one year's experience, after first testing the material on rabbit eyes and blind human eyes, I have found that most patients will tolerate the solution in up to 66% concentrations or higher without exhibiting an induced keratitis. In the higher concentrations, conjunctival irritation and injection may occur and warrant reduction of the concentration.Not a single significant (5 points or more) rise in intraocular pressure has been seen. The drug has been disappointing in the management of extraocular allergy, and
Gordon DM. DIMETHYLSULFOXIDE. Arch Ophthalmol. 1965;74(4):554. doi:https://doi.org/10.1001/archopht.1965.00970040556024
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: